Rankings
▼
Calendar
INDV Q3 2023 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena
INDV
Indivior Pharmaceuticals Inc
$4B
Q3 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$271M
+16.8% YoY
Gross Profit
$225M
83.0% margin
Operating Income
-$183M
-67.5% margin
Net Income
-$135M
-49.8% margin
EPS (Diluted)
$-0.94
QoQ Revenue Growth
-1.8%
Cash Flow
Operating Cash Flow
$21M
Free Cash Flow
$19M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$1.9B
Stockholders' Equity
-$24M
Cash & Equivalents
$610M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$271M
$232M
+16.8%
Gross Profit
$225M
$192M
+17.2%
Operating Income
-$183M
$56M
-426.8%
Net Income
-$135M
$41M
-429.3%
← FY 2023
All Quarters
Q4 2023 →